发明名称 PROTEINACEOUS ADJUVANTS
摘要 A modulated immune response to an antigen is achieved by coadministering the antigen and a genetically-detoxified pertussis holotoxin, particularly one retaining its immunogenicity, to a host. The modulated immune response enables immunogenic compositions, including multivalent pediatric vaccines such as DTP, to be provided which produce a modulated immune response in the absence of extrinsic adjuvants such as alum. The adjuvanting effect achieved by the genetically-detoxified pertussis holotoxin enables at least the same level of adjuvanting effect to be achieved as previously attained by alum, without the undesirable side effects thereof. <IMAGE>
申请公布号 PT1149589(E) 申请公布日期 2009.07.28
申请号 PT20010201610T 申请日期 1995.06.08
申请人 SANOFI PASTEUR LIMITED 发明人 HEATHER A. BOUX;MICHEL H. KLEIN;DIANE M. GAJEWCZYK;ANTON NOVAK
分类号 A61K39/39;A61K39/00;A61K39/10;A61K39/116;A61P31/00;A61P31/04;A61P31/12;A61P35/00;A61P37/04 主分类号 A61K39/39
代理机构 代理人
主权项
地址
您可能感兴趣的专利